ArticleInternational orthopaedics2021

Response to letter to the editor and comment concerning "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial".

Lu Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.